IL33 and type 2 diabetes mellitus: In obesity and T2D, the PD-1/PD-L1 pathway mediates the dysfunction of hypertrophic adipocytes, M2-to-M1 polarization, and IL-33 production, maintaining inflammation of WAT, and inducing systemic insulin resistance.